Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO To Track Rx Price Increases In Run-Up To Medicare Benefit

Executive Summary

The General Accounting Office will track increases in prescription drug prices in 2004-2006 that could drive up costs to the new Medicare drug benefit program

You may also be interested in...



Rx Prices For Medicare, Non-Medicare Groups Show Similar Growth – GAO

Retail prices for drugs frequently used by Medicare enrollees are increasing at a "similar" rate to those used by the non-Medicare population, the Government Accountability Office said

Rx Prices For Medicare, Non-Medicare Groups Show Similar Growth – GAO

Retail prices for drugs frequently used by Medicare enrollees are increasing at a "similar" rate to those used by the non-Medicare population, the Government Accountability Office said

Medicare Rx “Debit Card” Will Fund $5 Bil. In Drug Purchases, CMS Estimates

The Medicare discount card program will provide $2.4 bil. in federal funds to support drug purchases by low-income seniors during 2004, CMS estimates

Related Content

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel